SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+7.72%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$132M
AUM Growth
+$132M
(+1.5%)
Cap. Flow
-$11.7M
Cap. Flow
% of AUM
-8.9%
Top 10 Holdings %
Top 10 Hldgs %
55.66%
Holding
72
New
15
Increased
7
Reduced
12
Closed
11
Top Buys
| 1 |
HCA Healthcare
HCA
|
$5.27M |
| 2 |
Avanos Medical
AVNS
|
$3.95M |
| 3 |
Revvity
RVTY
|
$3.67M |
| 4 |
Elevance Health
ELV
|
$2.59M |
| 5 |
NTUS
Natus Medical Inc
NTUS
|
$2.54M |
Top Sells
| 1 |
Biogen
BIIB
|
$7.56M |
| 2 |
Puma Biotechnology
PBYI
|
$7M |
| 3 |
GSK
GSK
|
$6.4M |
| 4 |
Cardinal Health
CAH
|
$4.73M |
| 5 |
Sanofi
SNY
|
$4.25M |
Sector Composition
| 1 | Healthcare | 81.21% |
| 2 | Financials | 5.99% |
| 3 | Industrials | 3.57% |
| 4 | Technology | 1.12% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
QTNT
1
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $17.4M | 8.27% | 2,365,100 +27,039 | +1% | +$199K |
|
|
2
Sanofi
SNY
$121B
| $8.7M | 4.14% | 181,622 -88,800 | -33% | -$4.25M |
|
|
AET
3
DELISTED
Aetna Inc
AET
| $7.9M | 3.75% | 52,000 +14,900 | +40% | +$2.26M |
|
4
Philips
PHG
$26.2B
| $7.01M | 3.33% | 195,586 -48,600 | -20% | -$1.74M |
|
|
5
Puma Biotechnology
PBYI
$254M
| $6.99M | 3.32% | 80,021 -80,043 | -50% | -$7M |
|
6
Thermo Fisher Scientific
TMO
$186B
| $6.28M | 2.98% | 35,965 +5,965 | +20% | +$1.04M |
|
|
7
HCA Healthcare
HCA
$94.5B
| $5.27M | 2.5% | +60,420 | New | +$5.27M |
|
|
8
GSK
GSK
$79.9B
| $4.88M | 2.32% | 113,113 -148,400 | -57% | -$6.4M |
|
|
TRHC
9
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $4.71M | 2.24% | 312,630 -101,415 | -24% | -$1.53M |
|
|
AAAP
10
DELISTED
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
| $4.24M | 2.01% | 108,523 | – | – |
|
|
11
Avanos Medical
AVNS
$554M
| $3.95M | 1.88% | +100,599 | New | +$3.95M |
|
12
UnitedHealth
UNH
$281B
| $3.92M | 1.86% | 21,151 | – | – |
|
13
Globus Medical
GMED
$8.27B
| $3.76M | 1.79% | 113,400 +53,400 | +89% | +$1.77M |
|
14
Rigel Pharmaceuticals
RIGL
$697M
| $3.67M | 1.75% | 1,345,723 -542,458 | -29% | -$1.48M |
|
|
15
Revvity
RVTY
$10.5B
| $3.67M | 1.75% | +53,899 | New | +$3.67M |
|
16
Eli Lilly
LLY
$657B
| $2.76M | 1.31% | 33,473 -24,313 | -42% | -$2M |
|
17
Smith & Nephew
SNN
$16.3B
| $2.69M | 1.28% | 77,244 | – | – |
|
18
Medtronic
MDT
$119B
| $2.66M | 1.27% | 30,000 | – | – |
|
|
19
Elevance Health
ELV
$71.8B
| $2.59M | 1.23% | +13,767 | New | +$2.59M |
|
|
MZOR
20
DELISTED
Mazor Robotics Ltd.
MZOR
| $2.56M | 1.22% | 73,948 +42,483 | +135% | +$1.47M |
|
|
NTUS
21
DELISTED
Natus Medical Inc
NTUS
| $2.54M | 1.21% | +68,095 | New | +$2.54M |
|
|
NVRO
22
DELISTED
NEVRO CORP.
NVRO
| $2.48M | 1.18% | +33,250 | New | +$2.48M |
|
|
LMNX
23
DELISTED
Luminex Corp
LMNX
| $2.45M | 1.16% | +115,979 | New | +$2.45M |
|
|
ELGX
24
DELISTED
Endologix Inc
ELGX
| $2.4M | 1.14% | +493,060 | New | +$2.4M |
|
|
CCXI
25
DELISTED
ChemoCentryx, Inc.
CCXI
| $2.29M | 1.09% | 244,850 -49,300 | -17% | -$461K |
|